GSK-2838497A

N/A

Report date: 2025/03/26 20:01:25

Base Information

Drug NameGSK-2838497A

Drug Alias NameNon-typeable Haemophilus influenzae/pneumococcal adult vaccine - GlaxoSmithKline,Non-typeable Haemophilus influenzae (NTHi) vaccineGSK-2231395AGSK-2254232AGSK-2254233AGSK-2838497A +[16]

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiration DisordersPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumCanadaUnited States +[10]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsRespiration DisordersPneumococcal Infections

Other Information

ATC CodeN/A